2023-08-22 09:28:12 ET
- Trinity Capital Inc ( NASDAQ: TRIN ) Tuesday announced a commitment of $12 million in growth capital to Delphinus Medical Technologies, that has developed SoftVue, a dense breast screening innovation that increases cancer detection.
- The SoftVue 3D Whole Breast Ultrasound Tomography System was approved by the U.S. Food & Drug Administration (FDA) in October 2021.
- This growth capital will enable the team at Delphinus to continue to scale operations and broaden their impact in the global healthcare community.
- TRIN +2.02% premarket to $14.64
- Source: Press Release
For further details see:
Trinity Capital provides $12M growth capital to Delphinus Medical Technologies